Dose of Heptral
I cannot recommend a specific dose of Heptral for cholestatic liver disease based on the available evidence, as the provided FDA label 1 describes a homeopathic formulation (10 drops up to 3 times daily) for non-specific symptoms like fatigue and mood changes 1, which is entirely different from the pharmaceutical-grade S-adenosylmethionine (SAMe) used in hepatology.
Critical Clarification
The term "Heptral" appears to refer to different products in different contexts:
- The FDA-labeled product in the evidence is a homeopathic preparation for symptomatic relief of fatigue, weakness, and mood disturbances 1
- In hepatology literature, Heptral typically refers to pharmaceutical-grade S-adenosylmethionine (SAMe), used as an adjunct therapy in cholestatic liver diseases
Evidence for SAMe (Pharmaceutical Heptral) in Liver Disease
The only relevant clinical evidence provided shows:
- For primary biliary cirrhosis: SAMe (Heptral) was studied at 800-1600 mg/day in combination with ursodeoxycholic acid (UDCA) 2
- This combination promoted earlier disease remission and potentiated the cytoprotective and anticholestatic effects of UDCA 2
- SAMe was used as an adjunct to UDCA (10 mg/kg/day), not as monotherapy 2
Important Caveats
The homeopathic Heptral product 1 should not be confused with pharmaceutical SAMe used in hepatology. If you are asking about:
- Homeopathic Heptral: Follow the FDA label dosing of 10 drops up to 3 times daily 1, though this has no established role in treating liver disease
- Pharmaceutical SAMe (Heptral) for liver disease: The evidence supports 800-1600 mg/day as an adjunct to UDCA therapy 2, though this is based on limited data from a single small study
The gold standard for cholestatic liver disease remains UDCA at 13-15 mg/kg/day 3, with SAMe serving only as a potential adjunctive therapy in select cases.